• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性疼痛中的安慰剂:证据、理论、伦理及临床实践中的应用。

Placebos in chronic pain: evidence, theory, ethics, and use in clinical practice.

机构信息

Beth Israel Hospital/Harvard Medical School, Boston, MA 02139, USA.

Contributed equally.

出版信息

BMJ. 2020 Jul 20;370:m1668. doi: 10.1136/bmj.m1668.

DOI:10.1136/bmj.m1668
PMID:32690477
Abstract

Despite their ubiquitous presence, placebos and placebo effects retain an ambiguous and unsettling presence in biomedicine. Specifically focused on chronic pain, this review examines the effect of placebo treatment under three distinct frameworks: double blind, deception, and open label honestly prescribed. These specific conditions do not necessarily differentially modify placebo outcomes. Psychological, clinical, and neurological theories of placebo effects are scrutinized. In chronic pain, conscious expectation does not reliably predict placebo effects. A supportive patient-physician relationship may enhance placebo effects. This review highlights "predictive coding" and "bayesian brain" as emerging models derived from computational neurobiology that offer a unified framework to explain the heterogeneous evidence on placebos. These models invert the dogma of the brain as a stimulus driven organ to one in which perception relies heavily on learnt, top down, cortical predictions to infer the source of incoming sensory data. In predictive coding/bayesian brain, both chronic pain (significantly modulated by central sensitization) and its alleviation with placebo treatment are explicated as centrally encoded, mostly non-conscious, bayesian biases. The review then evaluates seven ways in which placebos are used in clinical practice and research and their bioethical implications. In this way, it shows that placebo effects are evidence based, clinically relevant, and potentially ethical tools for relieving chronic pain.

摘要

尽管安慰剂和安慰剂效应无处不在,但它们在生物医学中仍然存在着模糊和令人不安的存在。本综述特别关注慢性疼痛,考察了安慰剂治疗在三种不同框架下的效果:双盲、欺骗和开放标签如实处方。这些特定条件不一定会使安慰剂的效果产生差异。对安慰剂效应的心理、临床和神经学理论进行了仔细审查。在慢性疼痛中,有意识的期望并不能可靠地预测安慰剂效应。支持性的医患关系可能会增强安慰剂效应。本综述强调了“预测编码”和“贝叶斯大脑”作为新兴模型,这些模型源自计算神经生物学,为解释关于安慰剂的异质证据提供了一个统一的框架。这些模型颠覆了大脑作为受刺激驱动器官的教条,转而认为感知在很大程度上依赖于习得的、自上而下的皮层预测,以推断传入感觉数据的来源。在预测编码/贝叶斯大脑中,慢性疼痛(受中枢敏化显著调节)及其通过安慰剂治疗缓解都被解释为中枢编码的、主要是无意识的、贝叶斯偏见。然后,本综述评估了安慰剂在临床实践和研究中的七种用途及其生物伦理含义。通过这种方式,它表明安慰剂效应是基于证据的、临床相关的、缓解慢性疼痛的潜在伦理工具。

相似文献

1
Placebos in chronic pain: evidence, theory, ethics, and use in clinical practice.慢性疼痛中的安慰剂:证据、理论、伦理及临床实践中的应用。
BMJ. 2020 Jul 20;370:m1668. doi: 10.1136/bmj.m1668.
2
Against placebos.与安慰剂对照。
Am J Bioeth. 2009 Dec;9(12):23-5. doi: 10.1080/15265160903244234.
3
The paradoxical placebo.矛盾的安慰剂。
Am J Bioeth. 2009 Dec;9(12):17-20. doi: 10.1080/15265160903242733.
4
Open-Label Placebo: Reflections on a Research Agenda.开放标签安慰剂:关于研究议程的思考
Perspect Biol Med. 2018;61(3):311-334. doi: 10.1353/pbm.2018.0045.
5
Placebo is far from benign: it is disease-mongering.安慰剂远非无害:它是在制造疾病。
Am J Bioeth. 2009 Dec;9(12):36-8. doi: 10.1080/15265160903234078.
6
Biological, clinical, and ethical advances of placebo effects.安慰剂效应的生物学、临床和伦理进展。
Lancet. 2010 Feb 20;375(9715):686-95. doi: 10.1016/S0140-6736(09)61706-2.
7
Deliberate use of placebos in clinical practice: what we really know.临床实践中故意使用安慰剂:我们真正知道的。
J Med Ethics. 2012 Jul;38(7):406-7. doi: 10.1136/medethics-2012-100695. Epub 2012 May 28.
8
The Ethics of Placebo Effects in Clinical Practice and Research.安慰剂效应在临床实践和研究中的伦理问题。
Int Rev Neurobiol. 2018;139:463-484. doi: 10.1016/bs.irn.2018.07.031. Epub 2018 Aug 7.
9
Are open-Label Placebos Ethical? Informed Consent and Ethical Equivocations.开放标签安慰剂是否符合伦理?知情同意与伦理考量
Bioethics. 2016 Jul;30(6):407-14. doi: 10.1111/bioe.12245. Epub 2016 Feb 3.
10
Placebos in Australian general practice: A national survey of physician use, beliefs and attitudes.澳大利亚全科医疗中的安慰剂:一项针对医生使用、信念和态度的全国性调查。
Aust J Gen Pract. 2019 Dec;48(12):876-882. doi: 10.31128/AJGP-11-18-4755.

引用本文的文献

1
Design of a Randomized Sham-Controlled Trial: Strengthening Positive Treatment Expectations Using a Communication Model for Maximized Antiemetic Effects of Acupuncture and Antiemetics During Emetogenic Neo-/Adjuvant Chemotherapy.一项随机假对照试验的设计:使用一种沟通模型强化积极的治疗期望,以在致吐性新辅助/辅助化疗期间最大化针灸和止吐药的止吐效果。
Integr Cancer Ther. 2025 Jan-Dec;24:15347354251361464. doi: 10.1177/15347354251361464. Epub 2025 Aug 22.
2
Placebo and nocebo phenomena in schizophrenia spectrum disorders: a narrative review on current knowledge and potential future directions.精神分裂症谱系障碍中的安慰剂和反安慰剂现象:关于当前知识及潜在未来方向的叙述性综述
Psychol Med. 2025 Jul 18;55:e199. doi: 10.1017/S0033291725100901.
3
From catastrophizing to catalyzing: does pain catastrophizing modulate the beneficial impact of open-label placebos for chronic low back pain? A secondary analysis.从灾难化思维到催化作用:疼痛灾难化思维是否会调节开放标签安慰剂对慢性下腰痛的有益影响?一项二次分析。
Front Psychol. 2025 Jun 25;16:1522634. doi: 10.3389/fpsyg.2025.1522634. eCollection 2025.
4
A systematic review and meta analysis of open label placebo effects in chronic musculoskeletal pain.慢性肌肉骨骼疼痛中开放标签安慰剂效应的系统评价与荟萃分析
Sci Rep. 2025 Jul 5;15(1):24007. doi: 10.1038/s41598-025-09415-y.
5
Effectiveness of conditioning + open-label placebo for post-operative pain management in adolescent idiopathic scoliosis.条件训练 + 开放标签安慰剂用于青少年特发性脊柱侧弯术后疼痛管理的有效性
Pain Manag. 2025 Jul;15(7):363-371. doi: 10.1080/17581869.2025.2520148. Epub 2025 Jun 19.
6
Public psychology and holistic approaches to prevention and treatment of depression.公众心理与抑郁症防治的整体方法。
Front Psychiatry. 2025 Jun 3;16:1600094. doi: 10.3389/fpsyt.2025.1600094. eCollection 2025.
7
What are set and setting: Reducing vagueness to improve research and clinical practice.什么是环境与背景:减少模糊性以改善研究与临床实践。
J Psychopharmacol. 2025 May 26:2698811251337372. doi: 10.1177/02698811251337372.
8
Conditioned open-label placebos to facilitate opioid reduction in patients with chronic non-cancer pain: study protocol of a randomised controlled trial.条件性开放标签安慰剂用于促进慢性非癌性疼痛患者减少阿片类药物使用:一项随机对照试验的研究方案
BMJ Open. 2025 May 24;15(5):e098253. doi: 10.1136/bmjopen-2024-098253.
9
A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.裸盖菇素试验中使用的研究材料的全领域综述与分析:二十年研究评估
Psychedelic Med (New Rochelle). 2025 Feb 27;3(1):1-18. doi: 10.1089/psymed.2024.0019. eCollection 2025 Mar.
10
Prior therapeutic experiences and treatment expectations are differentially associated with pain-related disability in individuals with chronic pain.既往治疗经历和治疗期望与慢性疼痛患者的疼痛相关残疾存在不同程度的关联。
Sci Rep. 2025 Apr 26;15(1):14687. doi: 10.1038/s41598-025-98614-8.